Equities

SPO Global Inc

SPOM:PKC

SPO Global Inc

Actions
  • Price (USD)0.0018
  • Today's Change0.000 / -10.00%
  • Shares traded4.31m
  • 1 Year change-40.98%
  • Beta-6.2301
Data delayed at least 15 minutes, as of Sep 19 2024 20:46 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

SPO Global Inc. is a holding company. The Company is focused on holding interests in emerging young businesses, and provide financing, advice and guidance to the companies. The Company’s subsidiary is Gerpang Healthcare Company, which is located in Jinan Pharma Valley Industrial Park, High-tech District. Gerpang Healthcare Company main business scope includes bio-pharmaceutical research and development (R&D), development and sales of medical information software, medical high-tech introduction, production and sales of medical supplies, dietary supplement, medicine, as well as agents and sales of medical equipment supplies.

  • Revenue in USD (TTM)838.00k
  • Net income in USD-540.00k
  • Incorporated1981
  • Employees2.00
  • Location
    SPO Global Inc21860 Burbank BlvdNorth Building Suite 380WOODLAND HILLS 91367United StatesUSA
  • Phone+1 (818) 888-4380
  • Fax+1 (302) 655-5049
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
First Choice Healthcare Solutions Inc33.03m-3.07m187.86k53.00--0.0096--0.0057-0.1171-0.11711.080.59571.18--2.96---10.67-6.69-14.97-11.63-----9.08-6.00---52.960.0885---2.4449.84-142.38---35.31--
North America Frac Sand Inc0.00-226.72k192.22k3.00---------0.0034-0.00340.00-0.0122------0.00---5,915.30-----------193.66---16.94-----100.00--142.25------
Greenbrook TMS Inc75.21m-52.20m298.91k629.00------0.004-1.20-1.201.72-2.711.33--8.73---93.25-68.51-206.71-106.4528.2738.65-70.09-76.82---1.9920.04--10.4228.2644.21---54.79--
Dental Patient Care America Inc476.00k-513.00k426.67k4.00------0.8964-0.0215-0.01330.02-0.0305------119,000.00--------23.32---107.77-----3.25----51.11--32.14------
SPO Global Inc838.00k-540.00k617.35k2.00------0.7367-85.99-85.99131.76-476.561.76-------113.56-305.39----31.1527.31-64.44-384.85---1.45-----17.09-15.1313.03------
China Health Management Corp.483.00k-25.60m795.23k56.00------1.65-1,378.45-1,378.4525.37-41.350.04251.161.498,625.00-190.82---395.01---2,014.49---4,486.13--0.0203-1,353.25----37.69---363.55------
Mitesco Inc6.00k-4.15m909.28k3.00------151.55-0.6434-0.61210.0004-2.540.0332----2,000.00-1,094.48-246.54----0.00---33,009.50-29,214.62---0.7877---------59.12------
QHSLab Inc1.61m-190.50k1.03m4.00------0.6396-0.0199-0.01990.1649-0.03670.909731.8013.83403,272.50-10.74-51.17---197.3159.52---11.81-65.100.1152-0.2641.30--13.34--52.98------
Data as of Sep 19 2024. Currency figures normalised to SPO Global Inc's reporting currency: US Dollar USD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.